Related Experiment Video
Updated: May 12, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Transfusion requirements in acute coronary syndrome patients undergoing thrombolysis or anticoagulation: A
Subhash Chandra1, Varun Singh Sisodia2, Prachi Jain Rai1
1Department of Cardiology, UPUMS, Saifai, Etawah, India.
Bleeding complications and associated transfusion requirements remain a significant concern in patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis, yet data on transfusion needs and risk factors in resource-limited settings are limited. Therefore, it is of interest to assess transfusion requirements in 85 patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis at UPUMS, Saifai, from December 2024 to April 2025. Major bleeding requiring transfusion occurred in 4.7% (n=4) of patients, predominantly due to gastrointestinal sources (50%). The mean transfusion requirement was 2 units of packed red blood cells per bleeding event. Independent risk factors for major bleeding were age >65 years, chronic kidney disease and triple therapy (antiplatelet + anticoagulant + fibrinolytic). Bleeding was associated with significantly higher 30-day mortality (25% versus 5% in non-bleeders), highlighting the need for individualized antithrombotic strategies in ACS management.
Bleeding complications and associated transfusion requirements remain a significant concern in patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis, yet data on transfusion needs and risk factors in resource-limited settings are limited. Therefore, it is of interest to assess transfusion requirements in 85 patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis at UPUMS, Saifai, from December 2024 to April 2025. Major bleeding requiring transfusion occurred in 4.7% (n=4) of patients, predominantly due to gastrointestinal sources (50%). The mean transfusion requirement was 2 units of packed red blood cells per bleeding event. Independent risk factors for major bleeding were age >65 years, chronic kidney disease and triple therapy (antiplatelet + anticoagulant + fibrinolytic). Bleeding was associated with significantly higher 30-day mortality (25% versus 5% in non-bleeders), highlighting the need for individualized antithrombotic strategies in ACS management.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
